Novel Blood Biomarkers that Correlate with Cognitive Performance and Hippocampal Volumetry: Potential for Early Diagnosis of Alzheimer’s Disease
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel Blood Biomarkers that Correlate with Cognitive Performance and Hippocampal Volumetry: Potential for Early Diagnosis of Alzheimer’s Disease
Authors
Keywords
-
Journal
JOURNAL OF ALZHEIMERS DISEASE
Volume -, Issue -, Pages 1-17
Publisher
IOS Press
Online
2019-01-23
DOI
10.3233/jad-180879
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Increased Plasma Beta-Secretase 1 May Predict Conversion to Alzheimer’s Disease Dementia in Individuals With Mild Cognitive Impairment
- (2018) Yong Shen et al. BIOLOGICAL PSYCHIATRY
- Metabolomic Signatures in Peripheral Blood Associated with Alzheimer's Disease Amyloid-β-Induced Neuroinflammation
- (2018) Eosu Kim et al. JOURNAL OF ALZHEIMERS DISEASE
- Genome-Wide Serum microRNA Expression Profiling Identifies Serum Biomarkers for Alzheimer's Disease
- (2018) Lin Tan et al. JOURNAL OF ALZHEIMERS DISEASE
- Spreading of Amyloid, Tau, and Microvascular Pathology in Alzheimer's Disease: Findings from Neuropathological and Neuroimaging Studies
- (2018) Dietmar Rudolf Thal et al. JOURNAL OF ALZHEIMERS DISEASE
- Amino Acid Catabolism in Alzheimer’s Disease Brain: Friend or Foe?
- (2017) Jeddidiah W. D. Griffin et al. Oxidative Medicine and Cellular Longevity
- Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry
- (2017) Piotr Lewczuk et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- The impact of ageing reveals distinct roles for human dentate gyrus and CA3 in pattern separation and object recognition memory
- (2017) Serena E. Dillon et al. Scientific Reports
- Branched-chain amino acids and Alzheimer’s disease: a Mendelian randomization analysis
- (2017) Susanna C. Larsson et al. Scientific Reports
- Genetic Predisposition to an Impaired Metabolism of the Branched-Chain Amino Acids and Risk of Type 2 Diabetes: A Mendelian Randomisation Analysis
- (2016) Luca A. Lotta et al. PLOS MEDICINE
- First effects of rising amyloid-β in transgenic mouse brain: synaptic transmission and gene expression
- (2015) Damian M. Cummings et al. BRAIN
- Amyloid-β as a biomarker for Alzheimer’s disease: quantification methods in body fluids
- (2015) Sara Galozzi et al. Expert Review of Proteomics
- Hypervalinemia and hyperleucine-isoleucinemia caused by mutations in the branched-chain-amino-acid aminotransferase gene
- (2015) X. L. Wang et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Plasma proteins predict conversion to dementia from prodromal disease
- (2014) Abdul Hye et al. Alzheimers & Dementia
- Quantitative Analysis of Amyloid Deposition in Alzheimer Disease Using PET and the Radiotracer 11C-AZD2184
- (2014) H. Ito et al. JOURNAL OF NUCLEAR MEDICINE
- 18F-FDG PET and Perfusion SPECT in the Diagnosis of Alzheimer and Lewy Body Dementias
- (2014) J. T. O'Brien et al. JOURNAL OF NUCLEAR MEDICINE
- Plasma phospholipids identify antecedent memory impairment in older adults
- (2014) Mark Mapstone et al. NATURE MEDICINE
- Towards non-invasive diagnostic imaging of early-stage Alzheimer's disease
- (2014) Kirsten L. Viola et al. Nature Nanotechnology
- Prognostic classification of mild cognitive impairment and Alzheimer׳s disease: MRI independent component analysis
- (2014) Auriel A. Willette et al. PSYCHIATRY RESEARCH-NEUROIMAGING
- Glutamine synthetase in astrocytes from entorhinal cortex of the triple transgenic animal model of Alzheimer’s disease is not affected by pathological progression
- (2013) Chia-Yu Yeh et al. BIOGERONTOLOGY
- Progress Update: Fluid and Imaging Biomarkers in Alzheimer’s Disease
- (2013) Courtney L. Sutphen et al. BIOLOGICAL PSYCHIATRY
- Human Mild Traumatic Brain Injury Decreases Circulating Branched-Chain Amino Acids and Their Metabolite Levels
- (2013) Cameron B. Jeter et al. JOURNAL OF NEUROTRAUMA
- GWAS of Cerebrospinal Fluid Tau Levels Identifies Risk Variants for Alzheimer’s Disease
- (2013) Carlos Cruchaga et al. NEURON
- Branched-chain amino acid supplementation: impact on signaling and relevance to critical illness
- (2013) John S. A. Mattick et al. Wiley Interdisciplinary Reviews-Systems Biology and Medicine
- Distribution of the branched chain aminotransferase proteins in the human brain and their role in glutamate regulation
- (2012) Jonathon Hull et al. JOURNAL OF NEUROCHEMISTRY
- Feasibility of an early Alzheimer's disease immunosignature diagnostic test
- (2012) Lucas Restrepo et al. JOURNAL OF NEUROIMMUNOLOGY
- Glutamate system, amyloid β peptides and tau protein: functional interrelationships and relevance to Alzheimer disease pathology
- (2012) Timothy Revett et al. JOURNAL OF PSYCHIATRY & NEUROSCIENCE
- Blood and plasma-based proteomic biomarker research in Alzheimer's disease
- (2012) Simone Lista et al. PROGRESS IN NEUROBIOLOGY
- Alzheimer's disease diagnostic criteria: practical applications
- (2012) Jeffrey Cummings Alzheimers Research & Therapy
- Changes in plasma phenylalanine, isoleucine, leucine, and valine are associated with significant changes in intracranial pressure and jugular venous oxygen saturation in patients with severe traumatic brain injury
- (2011) Raphael N. Vuille-Dit-Bille et al. AMINO ACIDS
- Validation of Plasma Branched Chain Amino Acids as Biomarkers in Huntington Disease
- (2011) Fanny Mochel et al. ARCHIVES OF NEUROLOGY
- A Blood-Based Algorithm for the Detection of Alzheimer’s Disease
- (2011) Sid E. O’Bryant et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Medical Foods for Alzheimerʼs Disease
- (2011) Raj C. Shah DRUGS & AGING
- Advances in tau-based drug discovery
- (2011) Wendy Noble et al. Expert Opinion on Drug Discovery
- Plasma Clusterin and the Risk of Alzheimer Disease
- (2011) Elisabeth M. C. Schrijvers JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Serum Clusterin Levels Are Not Increased in Presymptomatic Alzheimer’s Disease
- (2011) Linda IJsselstijn et al. JOURNAL OF PROTEOME RESEARCH
- Age-dependent decrease in glutamine synthetase expression in the hippocampal astroglia of the triple transgenic Alzheimer's disease mouse model: mechanism for deficient glutamatergic transmission?
- (2011) Markel Olabarria et al. Molecular Neurodegeneration
- Preferential accumulation of amyloid-beta in presynaptic glutamatergic terminals (VGluT1 and VGluT2) in Alzheimer's disease cortex
- (2011) Sophie Sokolow et al. NEUROBIOLOGY OF DISEASE
- Association of Plasma Clusterin Concentration With Severity, Pathology, and Progression in Alzheimer Disease
- (2010) Madhav Thambisetty et al. ARCHIVES OF GENERAL PSYCHIATRY
- Homocysteine-Lowering by B Vitamins Slows the Rate of Accelerated Brain Atrophy in Mild Cognitive Impairment: A Randomized Controlled Trial
- (2010) A. David Smith et al. PLoS One
- Apolipoprotein E genotyping method by Real Time PCR, a fast and cost-effective alternative to the TaqMan® and FRET assays
- (2009) Olga Calero et al. JOURNAL OF NEUROSCIENCE METHODS
- Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
- (2009) Clifford R Jack et al. LANCET NEUROLOGY
- Reduced hippocampal glutamate in Alzheimer disease
- (2009) R. Rupsingh et al. NEUROBIOLOGY OF AGING
- Loss of VGLUT1 and VGLUT2 in the prefrontal cortex is correlated with cognitive decline in Alzheimer disease
- (2007) Alireza Kashani et al. NEUROBIOLOGY OF AGING
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started